• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Medical Device Problem Code Premature Activation (1484)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/25/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device analysis: visual examination revealed that the stent was 1 cm deployed at the tip and that there was a kink at the nose cone.Functional testing was completed using a stiff.035 guidewire.The wire was inserted into the sheath with no issue.Inspection of the remainder of the device revealed no other damage or irregularities.Product analysis confirmed the stent was partially deployed.
 
Event or Problem Description
It was reported that the stent partially deployed during prep.An eluvia drug-eluting vascular stent system was selected for use in the superficial femoral artery to treat a case of peripheral artery disease.During preparation for the procedure, it was noted that the eluvia us, 6x150, 130 cm was partially deployed outside of the patient.The eluvia was exchanged, and the procedure was completed with no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key20505611
Report Number2124215-2024-65120
Device Sequence Number12817680
Product Code NIU
UDI-Device Identifier08714729876625
UDI-Public08714729876625
Combination Product (Y/N)Y
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P180011
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 10/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/29/2026
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0034313770
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/07/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/25/2024
Initial Report FDA Received Date10/22/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/29/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-